Development of an orally bioavailable mSWI/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer
T. He, C. Cheng, Y. Qiao, H. Cho, E. Young, R. Mannan, S. Mahapatra, S. J. Miner, Y. Zheng, N. Kim, V. Z. Zeng, J. P. Wisniewski, S. Hou, B. Jackson, X. Cao, , A. M. Chinnaiyan
This paper develops an orally bioavailable PROTAC degrader of mSWI/SNF ATPases for prostate cancer and identifies resistance mechanisms through long-term treatment.
bioRxiv · Feb 29, 2024Cancer Biology